Evotec SE (EVO) Cost of Revenue (2009 - 2025)
Evotec SE (EVO) posted Cost of Revenue of $203474.8 for Q4 2025, up 6.16% sequentially from $191665.4 in Q3 2025, and up 8.75% YoY from $187111.1 in Q4 2024.
Evotec SE (EVO) Cost of Revenue (2009 - 2025) Analysis & Trends
Evotec SE has reported Cost of Revenue for 9 years, with the latest figure at $203474.8 in Q4 2025.
- Quarterly Cost of Revenue rose 8.75% year-over-year to $203474.8 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $765222.3 (down 24.9% YoY) and the FY2025 annual result came in at $784798.1, up 7.67% from the prior year.
- Cost of Revenue grew to $203474.8 in Q4 2025 per EVO's latest filing, from $191665.4 in the prior quarter.
- Over five years, Cost of Revenue peaked at $476349.8 in Q4 2023 and troughed at $123525.8 in Q1 2021.
- A 5-year average of $215867.9 and a median of $174575.3 in 2023 frame the typical range for Cost of Revenue.
- The widest YoY moves for Cost of Revenue: up 26.06% in 2021, down 99.88% in 2021.
- Over 5 years, Cost of Revenue stood at $379219.5 in 2021, then increased by 12.77% to $427636.7 in 2022, then climbed by 11.39% to $476349.8 in 2023, then sank by 60.72% to $187111.1 in 2024, then increased by 8.75% to $203474.8 in 2025.
- According to Business Quant data, Cost of Revenue over the past three periods registered $203474.8, $191665.4, and $187111.1 for Q4 2025, Q3 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | 1.99 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 2.55 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | 99.50 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 2.30 Bn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | 23.20 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 570.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Evotec SE | 681.90 Mn | 681.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 203,474.81 |
| Dec 31, 2025 | 203,474.81 |
| Sep 30, 2025 | 191,665.41 |
| Sep 30, 2025 | 191,665.41 |
| Dec 31, 2024 | 187,111.05 |
| Dec 31, 2024 | 187,111.05 |
| Sep 30, 2024 | 182,971.06 |
| Sep 30, 2024 | 182,971.06 |
| Dec 31, 2023 | 476,349.80 |
| Dec 31, 2023 | 476,349.80 |
| Sep 30, 2023 | 172,491.52 |
| Sep 30, 2023 | 172,491.52 |
| Jun 30, 2023 | 174,575.27 |
| Jun 30, 2023 | 174,575.27 |
| Dec 31, 2022 | 427,636.68 |
| Dec 31, 2022 | 427,636.68 |
| Sep 30, 2022 | 146,667.62 |
| Sep 30, 2022 | 146,667.62 |
| Jun 30, 2022 | 150,783.65 |
| Jun 30, 2022 | 150,783.65 |